Share Facebook Twitter LinkedIn Pinterest Email Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market
Intel to boost stake in SambaNova, chip startup chaired by Intel CEO Lip-Bu Tan – report (INTC:NASDAQ)April 2, 2026
Asian markets retreat as Trump’s 'nearing completion' address signals near-term escalationApril 2, 2026